HUM HUMANA INC

NYSE humana.com


$ 223.33 $ -5.61 (-2.45 %)    

Thursday, 20-Nov-2025 15:57:36 EST
QQQ $ 585.95 $ -14.20 (-2.37 %)
DIA $ 458.27 $ -3.66 (-0.79 %)
SPY $ 652.86 $ -10.10 (-1.52 %)
TLT $ 89.25 $ 0.35 (0.39 %)
GLD $ 374.63 $ -0.11 (-0.03 %)
$ 223.29
$ 231.34
$ 223.26 x 1
$ 223.33 x 5
$ 222.80 - $ 233.58
$ 206.15 - $ 314.25
1,426,558
na
26.86B
$ 0.40
$ 20.80
TBD
na
na ($ 0.02)
na
TBD na
How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In
# Filing Date Period End Date Type Report Link
1 11-05-2025 09-30-2025 10-Q
2 07-30-2025 06-30-2025 10-Q
3 04-30-2025 03-31-2025 10-Q
4 02-20-2025 12-31-2024 10-K
5 10-30-2024 09-30-2024 10-Q
6 07-31-2024 06-30-2024 10-Q
7 04-24-2024 03-31-2024 10-Q
8 02-15-2024 12-31-2023 10-K
9 11-01-2023 09-30-2023 10-Q
10 08-02-2023 06-30-2023 10-Q
11 04-26-2023 03-31-2023 10-Q
12 02-16-2023 12-31-2022 10-K
13 11-02-2022 09-30-2022 10-Q
14 07-27-2022 06-30-2022 10-Q
15 04-27-2022 03-31-2022 10-Q
16 02-17-2022 12-31-2021 10-K
17 11-03-2021 09-30-2021 10-Q
18 07-28-2021 06-30-2021 10-Q
19 04-28-2021 03-31-2021 10-Q
20 02-18-2021 12-31-2020 10-K
21 11-03-2020 09-30-2020 10-Q
22 08-05-2020 06-30-2020 10-Q
23 04-29-2020 03-31-2020 10-Q
24 02-20-2020 12-31-2019 10-K
25 11-06-2019 09-30-2019 10-Q
26 07-31-2019 06-30-2019 10-Q
27 05-01-2019 03-31-2019 10-Q
28 02-21-2019 12-31-2018 10-K
29 11-07-2018 09-30-2018 10-Q
30 08-01-2018 06-30-2018 10-Q
31 05-02-2018 03-31-2018 10-Q
32 02-16-2018 12-31-2017 10-K
33 11-08-2017 09-30-2017 10-Q
34 08-02-2017 06-30-2017 10-Q
35 05-03-2017 03-31-2017 10-Q
36 02-17-2017 12-31-2016 10-K
37 11-04-2016 09-30-2016 10-Q
38 08-03-2016 06-30-2016 10-Q
39 05-04-2016 03-31-2016 10-Q
40 02-18-2016 12-31-2015 10-K
Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In
# Date Analyst Firm Upside/Downside Price Target Change Rating Change Current Rating

News

OPINIONS

Core News & Articles

CNSide Diagnostics, LLC, a wholly-owned subsidiary of Plus Therapeutics, Inc. (Nasdaq: PSTV) ("Plus" or the "Compan...

 pete-buttigieg-slams-trumps-bad-deal-on-health-insurance-cites-cbo-estimate-of-10-premium-hikes-losing-on-the-economy

Pete Buttigieg says Trump's ATC attack is a distraction from his "bad deal" on health insurance and failure on "...

 insurers-slide-as-congress-postpones-decision-on-health-subsidies-delays-obamacare-subsidy-vote-to-december

Health insurer stocks fell after the Senate ended the shutdown without extending ACA subsidies, delaying the decision to Decemb...

 truist-securities-maintains-hold-on-humana-lowers-price-target-to-285

Truist Securities analyst David Macdonald maintains Humana (NYSE:HUM) with a Hold and lowers the price target from $300 to $...

Core News & Articles

https://trumpstruth.org/statuses/33744

 stocks-rebound-eli-lilly-jumps-to-14-month-highs-whats-moving-markets-wednesday

Wall Street bounced back Wednesday after Tuesday's sharp selloff in AI-driven stocks, as investors bought the dip amid soli...

 humana-q3-premium-growth-offsets-membership-drop-stock-tumbles

Humana beat Q3 estimates with $3.24 EPS and $32.65 billion sales, reaffirming 2025 earnings guidance at $17 per share despite M...

 humana-lowers-fy2025-gaap-eps-guidance-from-1377-to-1226-vs-1377-est

Humana (NYSE:HUM) lowers FY2025 GAAP EPS guidance from $13.77 to $12.26 vs $13.77 analyst estimate..

 humana-affirms-fy2025-adj-eps-guidance-of-1700-vs-1707-est

Humana (NYSE:HUM) affirms FY2025 Adj EPS guidance from $17.00 to $17.00 vs $17.07 analyst estimate..

 humana-q3-adj-eps-324-beats-282-estimate-sales-32649b-beat-32012b-estimate

Humana (NYSE:HUM) reported quarterly earnings of $3.24 per share which beat the analyst consensus estimate of $2.82 by 14.93 pe...

 nasdaq-dips-2-amid-pltr-decline-fear--greed-index-moves-to-extreme-fear-zone

The CNN Money Fear and Greed Index showed increased fear and U.S. stocks closed lower on Tuesday, led by declines in the Nasdaq.

 mcdonalds-pinterest-and-3-stocks-to-watch-heading-into-wednesday

U.S. stock futures mixed Wednesday. McDonald's, Pinterest, Qualcomm, AMD, Humana expected to report earnings.

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION